Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in mylan

New insulin glargine injection launched in US for diabetes patients

New insulin glargine injection launched in US for diabetes patients

Read More

COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir for 'restricted emergency use'

COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir for 'restricted emergency use'

Read More

Mylan announces commercial launch of its Remdesivir under brand name DESREMTM in India

Mylan announces commercial launch of its Remdesivir under brand name DESREMTM in India

Read More

Mylan-Biocon Combine’s Generic Insulin May Hit Market Sooner

Insulin glargin is a long-acting insulin analog used to treat adults with type 2 diabetes and adults and pediatric patients (children 6 years and older) with type 1 diabetes for the control of high blood sugar.

Read More

Biocon, Mylan Say Regulatory Submission For Insulin Glargine Accepted For Review

The two companies, which have co-developed insulin glargine, said they look forward to offering another insulin treatment option for diabetic patients

Read More

Mylan, Biocon Announce Regulatory Submission Accepted For Review By EMA

Biocon and Mylan are exclusive partners on a broad portfolio of biosimilars and generic insulin analogs

Read More

Govt Weighs Relaxing FDI Norms In Brownfield Pharma Companies

Government is considering a proposal to relax foreign direct investment norms in existing pharmaceutical companies with a view to attracting more overseas inflows

Read More